BiotechTube
Home/Aurinia Pharmaceuticals/Michael Hearne
MH

Michael Hearne

Chief Financial Officer

Aurinia Pharmaceuticals

Therapeutic Areas

Autoimmune DiseasesNephrologyRheumatology

Aurinia Pharmaceuticals Pipeline

DrugIndicationPhase
LUPKYNIS (voclosporin)Lupus NephritisApproved
AritinerceptAutoimmune DiseasesDiscovery/Preclinical
VoclosporinFocal Segmental Glomerulosclerosis (FSGS)Phase 2

Leadership Team at Aurinia Pharmaceuticals

KT
Kevin Tang
Chair of the Board and Chief Executive Officer
RC
Ryan Cole
Chief Operating Officer
SK
Stew Kroll
Chief Development Officer
JB
Jeffrey Bailey
Board Director
KG
Kathy Goetz
Board Director
CJ
Craig Johnson
Board Director
View full Aurinia Pharmaceuticals profile